|
LHFPL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.79665179903077E-12 |
| Normal-vs-Stage2 |
7.93650000000534E-05 |
| Normal-vs-Stage3 |
1.92478999999635E-05 |
| Normal-vs-Stage4 |
2.843900E-02 |
| Stage1-vs-Stage2 |
2.205600E-02 |
| Stage1-vs-Stage3 |
4.959400E-01 |
| Stage1-vs-Stage4 |
8.146400E-01 |
| Stage2-vs-Stage3 |
7.426400E-02 |
| Stage2-vs-Stage4 |
1.522810E-01 |
| Stage3-vs-Stage4 |
8.521000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
5.59600000005211E-07 |
| Normal-vs-Asian |
4.004200E-02 |
| Caucasian-vs-AfricanAmerican |
3.608400E-01 |
| Caucasian-vs-Asian |
3.410600E-01 |
| AfricanAmerican-vs-Asian |
2.238000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.13819953462269E-10 |
| Male-vs-Female |
6.038200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.05289999999358E-06 |
| Normal-vs-Extreme_Weight |
1.23489996006754E-09 |
| Normal-vs-Obese |
8.91759999177566E-09 |
| Normal-vs-Extreme_Obese |
3.184100E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.492400E-01 |
| Normal_Weight-vs-Obese |
4.855800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.706440E-02 |
| Extreme_Weight-vs-Obese |
5.524600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.517500E-03 |
| Obese-vs-Extreme_Obese |
1.681790E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.523510E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(61-80Yrs) |
2.16437978650674E-12 |
| Normal-vs-Age(81-100Yrs) |
9.477900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.146200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.941000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.099200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.924000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.580600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.601200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.38777878078145E-14 |
| Normal-VS-Type2 PRCC |
3.7251002282801E-10 |
| Normal-VS-KIRP CIMP |
1.790030E-02 |
| Normal-VS-Unclassified PRCC |
8.87600000054611E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.494000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.276600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.798000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.440600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.115600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.077700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.61910001966947E-09 |
| Normal-vs-N1 |
4.48550000000658E-05 |
| Normal-vs-N2 |
4.448000E-02 |
| N0-vs-N1 |
8.910200E-01 |
| N0-vs-N2 |
4.361000E-01 |
| N1-vs-N2 |
3.933400E-01 |
|
|
